Hints and tips:
Related Special Reports
...“There has been disappointment among the industry which had been preparing for production abroad,” she said, adding that competition for medical use was expected to grow as there was limited business opportunity...
...The pharmaceutical industry is also increasingly interested in the polygenic risk scores, which they can use to discover new targets for drugs, select patients for clinical trials, and expand the use of...
...A Humira biosimilar from Teva Pharmaceuticals working with Alvotech earlier this year became the first drug that the US Food and Drug Administration granted interchangeable status, which lets pharmacists...
...The leader of the pack was Teva Pharmaceuticals, whose market capitalisation reached $60bn in 2015. Teva now sits in the crosshairs of law enforcement....
...The push into prescriptions and drug delivery is unusual for a pharmaceutical manufacturer, pitting Eli Lilly against pharmacies such as CVS and Walgreens....
...The pharmaceutical industry is close to agreeing a deal with the UK government over drug pricing, according to the chief financial officer of Swiss drugmaker Novartis....
...The Association of the British Pharmaceutical Industry, the drugmakers’ trade body, said it supported “this tough deal” even though the agreement would continue to restrict pharmaceutical companies’ sales...
...There is limited data to track shortages in lower- and middle-income countries. But they are unable to compete on price with richer nations....
...But the proposal has run into opposition from the pharmaceutical industry....
...Generics have been the métier of Teva rather than genetics. It is here that the story starts darkening....
...“So it is particularly important to protect our limited [stock] of effective anti-fungal drugs.”...
..., food technology, pharmaceuticals and green tech....
...The order is the latest twist in frantic legal wrangling between anti-abortion campaigners, the US government and the pharmaceutical industry over the regulatory standing of mifepristone....
...Such orphan drugs are expected to account for more than a third of global sales at industry giant Johnson & Johnson in 2028, according to data group Evaluate. The same is expected of rival AstraZeneca....
...The decision is the latest twist in legal wrangling between anti-abortion campaigners, the Biden administration and the pharmaceutical industry over the regulatory standing of mifepristone....
...China’s economy is, after all, built on plans that lay out decades-long subsidies and protectionist ringfencing for the most strategic industries, including but not limited to clean energy, telecommunications...
...One pharmaceutical industry veteran said he welcomed any new initiative to develop medicines. But he added: “This approach looks remarkably complex.”...
...But Choi admits to still limited consumer adoption of immersive technology due to the clunky headsets and the lack of good content....
...While Covid-19 rapidly emptied cities and shut industries, long Covid has been more stealthy....
...Just a few decades ago, the vet sector was a cottage industry made up of vet-owned independent clinics....
...A second phase, which does not yet have a start date, will trial limited commercial sales — from which Curaleaf expects to benefit....
...Industry bites back Despite failing to persuade lawmakers last year to vote down the IRA, there is still a risk the pharmaceutical industry could block the reforms....
...At one point pharmaceutical company Pfizer even set out a “no jerks” policy....
...However, almost all large, western companies still in Russia have cut new investments and limited exports of goods to the country. Calculating losses is difficult....
...Fill your boots, says Barclays, whose buy recommendations include but are not limited to small caps . . ....
International Edition